BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29773592)

  • 1. Investigating chemoresistance to improve sensitivity of childhood T-cell acute lymphoblastic leukemia to parthenolide.
    Ede BC; Asmaro RR; Moppett JP; Diamanti P; Blair A
    Haematologica; 2018 Sep; 103(9):1493-1501. PubMed ID: 29773592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells.
    Wang J; Liu X; Qiu Y; Shi Y; Cai J; Wang B; Wei X; Ke Q; Sui X; Wang Y; Huang Y; Li H; Wang T; Lin R; Liu Q; Xiang AP
    J Hematol Oncol; 2018 Jan; 11(1):11. PubMed ID: 29357914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity.
    Abedi M; Rahgozar S; Esmaeili A
    Cancer Med; 2020 May; 9(10):3537-3550. PubMed ID: 32176452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia.
    Diamanti P; Cox CV; Moppett JP; Blair A
    Blood; 2013 Feb; 121(8):1384-93. PubMed ID: 23264600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
    Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
    Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies.
    Jorge J; Neves J; Alves R; Geraldes C; Gonçalves AC; Sarmento-Ribeiro AB
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalized Triblock Copolymer Vectors for the Treatment of Acute Lymphoblastic Leukemia.
    Deller RC; Diamanti P; Morrison G; Reilly J; Ede BC; Richardson R; Le Vay K; Collins AM; Blair A; Perriman AW
    Mol Pharm; 2017 Mar; 14(3):722-732. PubMed ID: 28139933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimyeloma effects of a sesquiterpene lactone parthenolide.
    Suvannasankha A; Crean CD; Shanmugam R; Farag SS; Abonour R; Boswell HS; Nakshatri H
    Clin Cancer Res; 2008 Mar; 14(6):1814-22. PubMed ID: 18347184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parthenolide induces significant apoptosis and production of reactive oxygen species in high-risk pre-B leukemia cells.
    Zunino SJ; Ducore JM; Storms DH
    Cancer Lett; 2007 Aug; 254(1):119-27. PubMed ID: 17470383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer.
    D'Anneo A; Carlisi D; Lauricella M; Puleio R; Martinez R; Di Bella S; Di Marco P; Emanuele S; Di Fiore R; Guercio A; Vento R; Tesoriere G
    Cell Death Dis; 2013 Oct; 4(10):e891. PubMed ID: 24176849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells.
    Cai J; Wang J; Huang Y; Wu H; Xia T; Xiao J; Chen X; Li H; Qiu Y; Wang Y; Wang T; Xia H; Zhang Q; Xiang AP
    Cell Death Dis; 2016 Nov; 7(11):e2459. PubMed ID: 27831567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin siRNA does not confer resistance to toxic effects of parthenolide in Jurkat cells.
    Mehri S; Mohammadi S; Nikbakht M; Sahmani M; Zahedpanah M
    Exp Oncol; 2020 Sep; 42(3):188-191. PubMed ID: 32996731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cell surface protein free thiols: a potential novel mechanism of action of the sesquiterpene lactone parthenolide.
    Skalska J; Brookes PS; Nadtochiy SM; Hilchey SP; Jordan CT; Guzman ML; Maggirwar SB; Briehl MM; Bernstein SH
    PLoS One; 2009 Dec; 4(12):e8115. PubMed ID: 19956548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia.
    Chu M; Yin K; Dong Y; Wang P; Xue Y; Zhou P; Wang Y; Wang Y
    Oncotarget; 2017 Jan; 8(1):1405-1415. PubMed ID: 27902457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells.
    Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH
    J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.
    Nakshatri H; Rice SE; Bhat-Nakshatri P
    Oncogene; 2004 Sep; 23(44):7330-44. PubMed ID: 15286701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parthenolide treatment activates stress signaling proteins in high-risk acute lymphoblastic leukemia cells with chromosomal translocation t(4;11).
    Zunino SJ; Storms DH; Ducore JM
    Int J Oncol; 2010 Nov; 37(5):1307-13. PubMed ID: 20878078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption.
    Zhao H; Shi P; Deng M; Jiang Z; Li Y; Kannappan V; Wang W; Li P; Xu B
    Oncotarget; 2016 Dec; 7(51):85515-85528. PubMed ID: 27888802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells.
    Zhang S; Ong CN; Shen HM
    Cancer Lett; 2004 May; 208(2):143-53. PubMed ID: 15142672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress.
    Burt R; Dey A; Aref S; Aguiar M; Akarca A; Bailey K; Day W; Hooper S; Kirkwood A; Kirschner K; Lee SW; Lo Celso C; Manji J; Mansour MR; Marafioti T; Mitchell RJ; Muirhead RC; Cheuk Yan Ng K; Pospori C; Puccio I; Zuborne-Alapi K; Sahai E; Fielding AK
    Blood; 2019 Oct; 134(17):1415-1429. PubMed ID: 31501154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.